|
84% of Type 2's think they're doing just fine. But in reality, 67% of those patients are out of control.
if they feel nothing's wrong, they see no need to do anything differently.
Get the Flash Player to see this movie.
It's been shown that a 1% reduction in A1C lowers
risk of complications such as eye, kidney and nerve
disease by 40%
Bayer's A1CNow+ monitor provides accurate,
in-office A1c results, empowering physicians to
make
on the spot treatment decisions for their
patients with diabetes.
Getting quick, accurate A!C results just got
even easier with the new
A1CNow+ Sampler.
- Only 5 UL of blood required
- Simple blood collection
- Fewer parts involved
- Easy disposal
Fast.
- In office testing. No waiting for lab results
- Results in just five minutes
- Hands-on procedure time is less than one minute
- Provides opportunity for immediate, face-to-face counseling
Easy.
- CLIA waived
- No calibration, no daily controls, no maintenance
- No refrigeration necessary if used within three months
- No capital equipment required
- Enables A1C testing in every exam room
Accurate.
- Proven lab accuracy at 99%
- NGSP certified
Clinical Accuracy
The A1CNow+ test is annually certified(7) by the National
Glycohemoglobin Standardization Program (NGSP) and therefore traceable
to the DCCT. Further, each lot is factory calibrated using a set of
blood samples that have been quantitated by an NGSP certified
laboratory using an NGSP certified method. Since in-field calibration
is neither needed nor possible, the user cannot alter the accuracy of
the test. Allowing for the normal variation seen with all laboratory
methods, a 7 percent A1C using A1CNow+ will thus be, on average, the
same as a 7 percent A1C on other instruments that are also calibrated
to NGSP standards.
Advanced Technology
- Uses micro-optical
technology that
provides results
equivalent to the
most sophisticated
lab equipment.
- Simultaneously
conducts two, independent
A1C tests
and compares the
results to ensure
accuracy.
- Utilizes both
immunoassay and
chemistry
technology
 |
The first single-use, quantitative test for long-term glucose
monitoring for people with diabetes. CLIA waiver is a regulatory status
available only for those diagnostic technologies deemed so simple to
use that the likelihood of an erroneous result is negligible, in
accordance with the Clinical Laboratory Improvement Amendments (CLIA).
For medical professional use only. This product cannot be purchased for personal or home use.
**Includes 1 test meter, 20 disposable test strips and 20 easy samplers.
Same great product now with new easy sampler.
Now with 20 tests per box.
|
|
|
|
|
|
|
